MA Richards

4.3k total citations · 1 hit paper
22 papers, 2.5k citations indexed

About

MA Richards is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, MA Richards has authored 22 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 8 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in MA Richards's work include Breast Cancer Treatment Studies (8 papers), Cancer survivorship and care (5 papers) and Global Cancer Incidence and Screening (4 papers). MA Richards is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Cancer survivorship and care (5 papers) and Global Cancer Incidence and Screening (4 papers). MA Richards collaborates with scholars based in United Kingdom, United States and Australia. MA Richards's co-authors include AJ Ramirez, Peter Littlejohns, S B Love, Janet Hardy, Patrick Stone, Roger A’Hern, Stephen Sutton, RD Rubens, Robert Huddart and DM Barnes and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

MA Richards

21 papers receiving 2.4k citations

Hit Papers

Influence of delay on survival in patients with breast ca... 1999 2026 2008 2017 1999 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Influence of delay on survival in patients with breast cancer: a systematic review
    1999 920 citations MA Richards, S B Love et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MA Richards United Kingdom 16 1.9k 526 351 266 245 22 2.5k
M A Richards United Kingdom 23 1.4k 0.7× 487 0.9× 214 0.6× 287 1.1× 94 0.4× 36 2.3k
Margaret Kemeny United States 23 1.4k 0.7× 862 1.6× 494 1.4× 314 1.2× 95 0.4× 71 2.7k
W D George United Kingdom 22 1.4k 0.8× 947 1.8× 316 0.9× 174 0.7× 131 0.5× 55 2.5k
D. Hole United Kingdom 25 931 0.5× 279 0.5× 376 1.1× 117 0.4× 148 0.6× 43 3.0k
Karen Ruth United States 33 1.2k 0.7× 579 1.1× 855 2.4× 329 1.2× 130 0.5× 129 3.3k
Adnan Ezzat Saudi Arabia 26 1.4k 0.7× 548 1.0× 667 1.9× 164 0.6× 218 0.9× 83 3.2k
Daphne Y. Lichtensztajn United States 25 1.2k 0.7× 900 1.7× 522 1.5× 339 1.3× 419 1.7× 56 2.6k
Paul Abrahamse United States 29 824 0.4× 663 1.3× 275 0.8× 387 1.5× 117 0.5× 86 2.4k
Michaela A. Dinan United States 31 969 0.5× 427 0.8× 536 1.5× 525 2.0× 112 0.5× 118 3.3k
Robin Zoň United States 25 931 0.5× 375 0.7× 517 1.5× 133 0.5× 107 0.4× 71 2.1k

Countries citing papers authored by MA Richards

Since Specialization
Citations

This map shows the geographic impact of MA Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MA Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MA Richards more than expected).

Fields of papers citing papers by MA Richards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MA Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MA Richards. The network helps show where MA Richards may publish in the future.

Co-authorship network of co-authors of MA Richards

This figure shows the co-authorship network connecting the top 25 collaborators of MA Richards. A scholar is included among the top collaborators of MA Richards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MA Richards. MA Richards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rozen, Paul, Michael Pignone, Michele Crespi, et al.. (2004). Workgroup V: professional education and advocacy. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002). Annals of Oncology. 16(1). 42–45. 1 indexed citations
2.
Stone, Patrick, Janet Hardy, Robert Huddart, Roger A’Hern, & MA Richards. (2000). Fatigue in patients with prostate cancer receiving hormone therapy. European Journal of Cancer. 36(9). 1134–1141. 197 indexed citations
3.
Stone, Patrick, MA Richards, Roger A’Hern, & Janet Hardy. (2000). A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Annals of Oncology. 11(5). 561–568. 245 indexed citations
4.
Ramirez, AJ, et al.. (1999). Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. The Lancet. 353(9159). 1127–1131. 395 indexed citations
5.
Richards, MA, et al.. (1999). Influence of delay on survival in patients with breast cancer: a systematic review. The Lancet. 353(9159). 1119–1126. 920 indexed citations breakdown →
6.
Stone, Patrick, Janet Hardy, Robert Huddart, MA Richards, & Roger A’Hern. (1999). Fatigue in patients with prostate cancer receiving hormone therapy. Palliative Medicine. 13(6). 517–517. 3 indexed citations
7.
Richards, MA, et al.. (1999). Delay in diagnosis in breast cancer. The Lancet. 353(9170). 2155–2155. 8 indexed citations
8.
Statham, Helen, et al.. (1997). Genetic counselling for breast and ovarian cancer: Why do women attend?. 8. 179–180. 3 indexed citations
9.
Wang, Dong‐Yu, et al.. (1996). Serum progesterone and prognosis in operable breast cancer. British Journal of Cancer. 73(12). 1552–1555. 34 indexed citations
10.
11.
Twelves, C.J., David A. Porter, M. Lowry, et al.. (1994). Phosphorus-31 metabolism of post-menopausal breast cancer studied in vivo by magnetic resonance spectroscopy. British Journal of Cancer. 69(6). 1151–1156. 25 indexed citations
12.
Twelves, C.J., et al.. (1994). Iododoxorubicin in advanced breast cancer: a phase II evaluation of clinical activity, pharmacology and quality of life. British Journal of Cancer. 69(4). 726–731. 18 indexed citations
13.
Patel, Ketan, et al.. (1994). The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma. British Journal of Cancer. 70(2). 335–341. 115 indexed citations
14.
Hill, ME, MA Richards, WM Gregory, Paul Smith, & RD Rubens. (1993). Spinal cord compression in breast cancer: a review of 70 cases. British Journal of Cancer. 68(5). 969–973. 51 indexed citations
15.
Ramirez, AJ, SR Ebbs, Lesley Fallowfield, et al.. (1993). A daily diary for quality of life measurement in advanced breast cancer trials. British Journal of Cancer. 67(2). 341–346. 42 indexed citations
16.
Barnes, DM, et al.. (1991). The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer. British Journal of Cancer. 63(3). 444–446. 120 indexed citations
17.
Camplejohn, RS, et al.. (1990). DNA index, S-phase fraction, histological grade and prognosis in breast cancer. British Journal of Cancer. 61(5). 671–674. 99 indexed citations
18.
Twelves, C.J., et al.. (1989). Weekly epirubicin for breast cancer with liver metastases and abnormal liver biochemistry. British Journal of Cancer. 60(6). 938–941. 26 indexed citations
19.
Tebbi, Cameron K., et al.. (1988). The role of parent-adolescent concordance in compliance with cancer chemotherapy.. PubMed. 23(91). 599–611. 28 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M A Richards Breakdown of academic impact, for papers by Margaret Kemeny Breakdown of academic impact, for papers by W D George Breakdown of academic impact, for papers by D. Hole Breakdown of academic impact, for papers by Karen Ruth Breakdown of academic impact, for papers by Adnan Ezzat Breakdown of academic impact, for papers by Daphne Y. Lichtensztajn Breakdown of academic impact, for papers by Paul Abrahamse Breakdown of academic impact, for papers by Michaela A. Dinan Breakdown of academic impact, for papers by Robin Zoň
Rankless by CCL
2026